NEW HOPE(000876) 环球网· Huan Qiu Wang·2025-05-20 02:39Core Viewpoint - The conference highlighted the innovative application of the theory of "Luo Disease" in the diagnosis and treatment of prostate diseases, particularly focusing on the clinical research progress of the innovative Chinese medicine Xia Li Qi capsules, providing new solutions for the health of middle-aged and elderly men [1][3]. Group 1: Prostate Disease Insights - Prostate hyperplasia is the most common benign disease causing lower urinary tract symptoms in elderly men, with an incidence rate exceeding 50% in men over 60 years old and reaching 83% by age 80 [3]. - Traditional Chinese medicine categorizes prostate hyperplasia as "Luo Bi," primarily caused by "kidney deficiency and bladder dysfunction" [3]. Group 2: Xia Li Qi Capsules - Xia Li Qi capsules are developed based on the theory of Luo Disease, featuring a formulation that combines various herbs to create a treatment system that addresses both symptoms and root causes [4]. - Clinical studies have shown that Xia Li Qi capsules significantly reduce the International Prostate Symptom Score (IPSS), improve symptoms like urinary urgency and frequency, and effectively inhibit prostate enlargement [4]. Group 3: Clinical Guidelines and Future Directions - Xia Li Qi capsules have been included in multiple authoritative guidelines and consensus documents related to the management of benign prostate hyperplasia, establishing them as a preferred option for integrated treatment [5]. - The current treatment landscape for prostate hyperplasia faces challenges with symptom management, necessitating the exploration of traditional Chinese medicine's holistic approach for better disease management [5].